Roger Dansey – Biography
Last update: April 21, 2026Executive profile
Roger was Senior Vice President at Merck, and Vice President, Oncology Clinical Research at Gilead Sciences. Roger Dansey joined Inovio Pharmaceuticals in 2025.
Roger Dansey is currentlyDirector at Bicycle Therapeutics - View - Bicycle Therapeutics org chart
Director at Inovio Pharmaceuticals - View - Inovio Pharmaceuticals org chart
Director at Nurix Therapeutics - View - Nurix Therapeutics org chart
Director at Shasqi - View - Shasqi org chart
Create your alert
to follow the career of Roger Dansey.
Education
In 1987, Roger Dansey completed a Master in Internal Medicine at University of Waterloo.
They have also studied at University of Waterloo :
Find more alumni from University of Waterloo
More about Roger Dansey
Selected links
Do you need to know more about Roger Dansey? More results.
Participate
Social media
- Roger Dansey on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Roger Dansey
The colleagues of Roger Dansey
Company Colleagues
- At Bicycle Therapeutics, Roger Dansey has 27 colleagues including Kevin Lee (CEO & Director), Jose-Carlos Gutierrez (Director)…
- At Inovio Pharmaceuticals, Roger Dansey has 21 colleagues including Jacqueline Shea (CEO & President), Wendy Yarno (Director)…
- At Nurix Therapeutics, Roger Dansey has 34 colleagues including Arthur Sands (CEO & Director), Judith Reinsdorf (Director)…
- At Shasqi, Roger Dansey has 7 colleagues including José Mejía Oneto (CEO & Director), Robin Schulman (Director)…
Industry Colleagues
- In the Biotechnology industry, Roger Dansey has 35,762 colleagues in 2,407 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Roger Dansey.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Roger Dansey.
